Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis

被引:0
|
作者
Sato, Takeo [1 ]
Inokuma, Shigeko [1 ]
机构
[1] Japanese Red Cross Med Ctr, Dept Allerg Dis & Rheumatol, Shibuya Ku, Tokyo 1508935, Japan
关键词
D O I
10.1093/rheumatology/keq106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1607 / 1607
页数:1
相关论文
共 50 条
  • [31] Enteric-coated mycophenolate sodium for progressive systemic sclerosis-a prospective open-label study with CT histography for monitoring of pulmonary fibrosis
    Henes, Joerg C.
    Horger, Marius
    Amberger, Christopher
    Schmalzing, Marc
    Fierlbeck, Gerhard
    Kanz, Lothar
    Koetter, Ina
    CLINICAL RHEUMATOLOGY, 2013, 32 (05) : 673 - 678
  • [32] A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
    Spierings, Julia
    van Rhenen, Anna
    Welsing, Paco M. W.
    Marijnissen, Anne C. A.
    De Langhe, Ellen
    Del Papa, Nicoletta
    Dierickx, Daan
    Gheorghe, Karina R.
    Henes, Joerg
    Hesselstrand, Roger
    Kerre, Tessa
    Ljungman, Per
    van de Loosdrecht, Arjan A.
    Marijt, Erik W. A. F.
    Mayer, Miro
    Schmalzing, Marc
    Schroers, Roland
    Smith, Vanessa
    Voll, Reinhard E.
    Vonk, Madelon C.
    Voskuyl, Alexandre E.
    de Vries-Bouwstra, Jeska K.
    Walker, Ulrich A.
    Wuttge, Dirk M.
    van Laar, Jacob M.
    BMJ OPEN, 2021, 11 (03):
  • [33] Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial
    Strueber, M.
    Warnecke, G.
    Fuge, J.
    Simon, A. R.
    Zhang, R.
    Welte, T.
    Haverich, A.
    Gottlieb, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3171 - 3180
  • [34] An open-label 12-month trial of mycophenolate mofetil in myasthenia gravis
    Gogovska, L.
    Ljapcev, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 273 - 273
  • [35] Mycophenolate mofetil for the treatment of chronic dermatitis: An open label-study of 16 patients
    Jackson, JM
    Fowler, JE
    Callen, JP
    Lorenz, DJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : AB6 - AB6
  • [36] Safety and Efficacy of Lenabasum in an Open-Label Extension of a Phase 2 Study in Diffuse Cutaneous Systemic Sclerosis Subjects
    Spiera, Robert F.
    Hummers, Laura K.
    Chung, Lorinda
    Frech, Tracy M.
    Domsic, Robyn T.
    Hsu, Vivien
    Furst, Daniel E.
    Gordon, Jessica K.
    Mayes, Maureen D.
    Simms, Robert W.
    Lee, Elizabeth
    Constantine, Scott
    White, Barbara
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [37] Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
    Melsens, Karin
    Vandecasteele, Els
    Deschepper, Ellen
    Badot, Valerie
    Blockmans, Daniel
    Brusselle, Guy
    De Langhe, Ellen
    De Pauw, Michel
    Debusschere, Claire
    Decuman, Saskia
    Deroo, Liselotte
    Houssiau, Frederic
    Lenaerts, Jan
    Piette, Yves
    Thevissen, Kristof
    Vanthuyne, Marie
    Westhovens, Rene
    Wijnant, Sara
    De Keyser, Filip
    Smith, Vanessa
    ACTA CLINICA BELGICA, 2018, 73 (02) : 119 - 125
  • [38] THE EFFECTS OF BOSENTAN FOR TREATMENT OF DIGITAL ULCER IN KOREAN PATIENTS WITH SYSTEMIC SCLEROSIS: PROSPECTIVE, MULTICENTER, OPEN-LABEL TRIAL
    Lee, Kyung Ann
    Kim, Hyun-Sook
    Kim, Bo Young
    Kim, Yun Sung
    Choi, Sung Jae
    Choi, Jung Ran
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1795 - 1796
  • [39] Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial
    Fernandez-Codina, Andreu
    Nevskaya, Tatiana
    Baron, Murray
    Appleton, C. Thomas
    Cecchini, Matthew J.
    Philip, Amanda
    El-Shimy, Maha
    Vanderhoek, Louise
    Pinal-Fernandez, Iago
    Pope, Janet E.
    RHEUMATOLOGY, 2024,
  • [40] A Macrophage-Specific Mechanism for Mycophenolate Mofetil in the Treatment of Systemic Sclerosis
    Morris, Emily
    Parvizi, Rezvan
    Pioli, Patricia
    Whitfield, Michael
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4671 - 4673